Greenberg Traurig Patent Attorney, Dr. Fang Xie, Recognized in IAM Strategy 300 - The World’s Leading IP Strategists 2017

Share Article

Dr. Fang Xie was recognized as one of the world’s top intellectual property (IP) value creators in the 2017 edition of the Intellectual Asset Management’s (IAM) Strategy 300 – The World’s Leading IP Strategists 2017.

Dr. Fang Xie, a registered patent attorney and co-leader of Greenberg Traurig, LLP’s Biotechnology and Pharmaceutical Industry Group in the firm’s Boston office, was recognized as one of the world’s top intellectual property (IP) value creators in the 2017 edition of the Intellectual Asset Management’s (IAM) Strategy 300 – The World’s Leading IP Strategists 2017. According to the publication, the guide identifies the individuals who are leading the way in the development and implementation of strategies that maximize the value of IP portfolios. This is Dr. Xie’s second consecutive year being named to this prestigious list.

Dr. Xie is of counsel in the firm’s Intellectual Property Practice, focusing her practice on establishing, defending, licensing, sharing, and monetizing intellectual property rights for life sciences companies. She has broad experience in worldwide patent portfolio development, intellectual property due diligence, licensing and technology transfer, patentability and product clearance studies, validity/invalidity analyses, patent infringement evaluations, as well as intellectual property litigation and pre-litigation counseling. Dr. Xie’s primary technical areas include biotechnology, synthetic biology, and pharmaceuticals, with a focus on immunotherapy, antibody and biologics/biosimilars, nucleic acid synthesis, gene editing, protein and organism engineering, stem cell technology, biomarkers, diagnostics, small molecule drugs, regenerative medicine, analytical chemistry, and cosmetics. She regularly works with clients in the life sciences sector, including biotechnology, pharmaceutical, and chemistry companies, as well as venture capital and institutional investors. Dr. Xie also frequently works with early-stage bio-pharmaceutical companies to enhance their IP position and develop licensing and partnership strategies.

About Greenberg Traurig’s Boston Office

Established in 1999, Greenberg Traurig’s Boston office is home to nearly 70 attorneys practicing in the areas of corporate, emerging technology, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, and real estate. An important contributor to the firm's international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of legal experience and hands-on knowledge of the local business community, supported by the firm's vast network of global resources.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP (GTLaw) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East and is celebrating its 50th anniversary. GTLaw has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and among the Top 20 on the 2016 Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo Martinez
Greenberg Traurig
+1 (212) 801-2131
Email >
Visit website